LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.51 | 17.25 | 812 | 2906 | 0.2794 | 0.6833 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.51 | 17.25 | 5 | 2906 | 0.0017 | -0.1542 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.51 | 17.25 | 934 | 2906 | 0.3214 | 0.7155 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.48 | 17.25 | 459 | 3125 | 0.1468 | 0.5487 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.48 | 17.25 | 850 | 3125 | 0.2719 | 0.6813 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.48 | 17.25 | 2 | 3125 | 0.0006 | -0.2497 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.48 | 17.25 | 957 | 3125 | 0.3062 | 0.7081 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.45 | 17.25 | 542 | 3504 | 0.1547 | 0.5678 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.45 | 17.25 | 846 | 3504 | 0.2414 | 0.6616 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.45 | 17.25 | 2 | 3504 | 0.0006 | -0.2450 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.45 | 17.25 | 963 | 3504 | 0.2748 | 0.6899 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.42 | 17.25 | 543 | 3895 | 0.1394 | 0.5545 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.42 | 17.25 | 882 | 3895 | 0.2264 | 0.6540 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.42 | 17.25 | 1 | 3895 | 0.0003 | -0.3053 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.42 | 17.25 | 952 | 3895 | 0.2444 | 0.6702 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 46.39 | 17.25 | 569 | 4141 | 0.1374 | 0.5560 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 46.39 | 17.25 | 867 | 4141 | 0.2093 | 0.6411 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 46.39 | 17.25 | 3 | 4141 | 0.0007 | -0.1985 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 46.39 | 17.25 | 974 | 4141 | 0.2352 | 0.6655 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 48.36 | 17.25 | 656 | 4390 | 0.1494 | 0.5766 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 48.36 | 17.25 | 859 | 4390 | 0.1957 | 0.6307 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 48.36 | 17.25 | 6 | 4390 | 0.0014 | -0.1238 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 48.36 | 17.25 | 977 | 4390 | 0.2225 | 0.6572 | MN20160310_N02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.33 | 17.25 | 736 | 4651 | 0.1582 | 0.5917 | MN20160310_N02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 50.33 | 17.25 | 858 | 4651 | 0.1845 | 0.6223 | MN20160310_N02 | E08 |